Motif Bio plc (AIM: MTFB) the clinical stage biopharmaceutical company specialising in developing novel antibiotics, announces that its Annual Report and Accounts 2015 is now available on its website:
http://www.motifbio.com/investors
For further information please contact:
Motif Bio plc
Graham Lumsden (Chief Executive Officer)
David Huang (Chief Medical Officer)
info@motifbio.com
Zeus Capital Limited (NOMAD & BROKER)
Phil Walker/Dan Bate
Dominic Wilson
+44 (0)20 3829 5000
Northland Capital Partners Limited (BROKER)
Patrick Claridge/ David Hignell
John Howes/ Rob Rees (Broking)
+44 (0)20 3861 6625
Walbrook PR Ltd. (FINANCIAL PR & IR)
Paul McManus
Mike Wort
+44 (0)20 7933 8780 or motifbio@walbrookpr.com
Mob: +44 (0)7980 541 893
Mob: +44 (0)7900 608 002
MC Services AG (EUROPEAN IR)
Raimund Gabriel
+49 (0)89 210 2280
